ALFA Filings
Every announcement, straight from the exchange
Every Accent Microcell earnings call announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
Accent Microcell transcript for FY26 results highlights growth driven by high-value premium products (MCC spheres, SMCC) and upcoming capacity expansion via Unit 3.
Accent Microcell reported FY26 revenue of ₹34,903 Lakhs (up 31.92% YoY) and PAT of ₹4,385 Lakhs (up 32.65% YoY), driven by strong export growth and expansion in pharmaceutical excipients.
Accent Microcell delivered record H2 results driven by a strategic shift toward premium products like MCC spheres, though Unit 3 delays at Navagam remain a point of concern for immediate scaling.